Stock Track | Myriad Genetics Soars 5% as Wells Fargo Raises Target Price

Stock Track11-05

Shares of Myriad Genetics (MYGN) are soaring in Wednesday's trading session, showing a significant uptick of 5.03%. This notable movement comes on the heels of a positive development from a major Wall Street firm.

Wells Fargo, a prominent financial institution, has raised its target price for Myriad Genetics from $6 to $6.5. This adjustment represents an 8.33% increase in the bank's valuation of the company's stock. Such revisions from respected financial analysts often carry weight with investors and can influence trading patterns.

The increase in target price typically signals that analysts at Wells Fargo have become more optimistic about Myriad Genetics' future prospects. This could be based on various factors, such as improved financial performance, positive industry trends, or promising developments within the company. As investors digest this new information, it appears to be translating into increased demand for MYGN shares, driving the stock's impressive intraday gain.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1152828013?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 23:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1152828013","market":"hk","top_or_hot":-1,"title":"Stock Track | Myriad Genetics Soars 5% as Wells Fargo Raises Target Price","media":"Stock Track","content":"<p>Shares of Myriad Genetics (MYGN) are soaring in Wednesday's trading session, showing a significant uptick of 5.03%. This notable movement comes on the heels of a positive development from a major Wall Street firm.</p>\n\n<p>Wells Fargo, a prominent financial institution, has raised its target price for Myriad Genetics from $6 to $6.5. This adjustment represents an 8.33% increase in the bank's valuation of the company's stock. Such revisions from respected financial analysts often carry weight with investors and can influence trading patterns.</p>\n\n<p>The increase in target price typically signals that analysts at Wells Fargo have become more optimistic about Myriad Genetics' future prospects. This could be based on various factors, such as improved financial performance, positive industry trends, or promising developments within the company. As investors digest this new information, it appears to be translating into increased demand for MYGN shares, driving the stock's impressive intraday gain.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Myriad Genetics Soars 5% as Wells Fargo Raises Target Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Myriad Genetics Soars 5% as Wells Fargo Raises Target Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-05 23:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Myriad Genetics (MYGN) are soaring in Wednesday's trading session, showing a significant uptick of 5.03%. This notable movement comes on the heels of a positive development from a major Wall Street firm.</p>\n\n<p>Wells Fargo, a prominent financial institution, has raised its target price for Myriad Genetics from $6 to $6.5. This adjustment represents an 8.33% increase in the bank's valuation of the company's stock. Such revisions from respected financial analysts often carry weight with investors and can influence trading patterns.</p>\n\n<p>The increase in target price typically signals that analysts at Wells Fargo have become more optimistic about Myriad Genetics' future prospects. This could be based on various factors, such as improved financial performance, positive industry trends, or promising developments within the company. As investors digest this new information, it appears to be translating into increased demand for MYGN shares, driving the stock's impressive intraday gain.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MYGN","symbol_name":"万基遗传","start_time":0,"source_url":"","article_id":"1152828013","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1152828013","pubTimestamp":1762358066,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Myriad Genetics (MYGN) are soaring in Wednesday's trading session, showing a significant uptick of 5.03%. This notable movement comes on the heels of a positive development from a major...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MYGN":"万基遗传"},"translate_title":"个股追踪|富国银行上调目标价Myriad Genetics大涨5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MYGN":1},"content_text":"Shares of Myriad Genetics (MYGN) are soaring in Wednesday's trading session, showing a significant uptick of 5.03%. This notable movement comes on the heels of a positive development from a major Wall Street firm.\nWells Fargo, a prominent financial institution, has raised its target price for Myriad Genetics from $6 to $6.5. This adjustment represents an 8.33% increase in the bank's valuation of the company's stock. Such revisions from respected financial analysts often carry weight with investors and can influence trading patterns.\nThe increase in target price typically signals that analysts at Wells Fargo have become more optimistic about Myriad Genetics' future prospects. This could be based on various factors, such as improved financial performance, positive industry trends, or promising developments within the company. As investors digest this new information, it appears to be translating into increased demand for MYGN shares, driving the stock's impressive intraday gain.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1152828013","isCrawlerRequest":true}